Delphia (USA)’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-5,054
Closed -$205K 275
2022
Q4
$205K Buy
+5,054
New +$205K 0.24% 196